See all treatments in the PatientsLikeMe system shared by patients just like you.
What is Research Study BEYOND?
BEYOND study looks at whether increasing the dose of Betaseron to 500 mcg might result in fewer relapses for previously untreated MS patients. The study compared the effectiveness and tolerability of Betaseron 500 mcg with Betaseron 250 mcg, and Copaxone® 20 mg, a non-interferon MS therapy.
Read more...